Work

Artesunate overcomes lenvatinib resistance by inhibiting the STAT3/SLC25A27 pathway and promoting ferroptosis in hepatocellular carcinoma

Year: 2026

Type: article

Source: Current Cancer Drug Targets

DOI: 10.2174/0115680096426616260214221301

Authors: Ranran Bi, Luyuan Ma, Ruolan Gu, Shilong Dong, Xinyang Li, Wenpeng Liu, Pengfei Zhang, Feng Gao, Chuan Shen, Caiyan Zhao

Institutions: Hebei Medical University, Third Hospital of Hebei Medical University

Language: English

Topic: Ferroptosis and cancer prognosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148394685

FWCI:

Cites:

Cited by:

Related to: